223 related articles for article (PubMed ID: 28578712)
1. PHARMACOECONOMIC STUDIES IN WORLD HEALTH ORGANIZATION EASTERN MEDITERRANEAN COUNTRIES: REPORTING COMPLETENESS.
Alefan Q; Rascati K
Int J Technol Assess Health Care; 2017 Jan; 33(2):215-221. PubMed ID: 28578712
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications for China.
Jiang S; Ma X; Desai P; Yang L; Rascati K
Value Health Reg Issues; 2014 May; 3():79-86. PubMed ID: 29702942
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the quality and trend of reporting of health economic evaluation research in India.
Karekar S; Shetty Y
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):595-599. PubMed ID: 33249942
[No Abstract] [Full Text] [Related]
4. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
[TBL] [Abstract][Full Text] [Related]
5. Reporting Quality of Cost-Effectiveness Analyses Conducted in Saudi Arabia: A Systematic Review.
Algarni MA; Alqahtani SS; Alshehri AM; Alanazi AS; Alzahrani MS; Alolayan SO; Alzarea AI
Value Health Reg Issues; 2021 Sep; 25():99-103. PubMed ID: 33848894
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of Hospital and Community Pharmacy Services.
Gammie T; Vogler S; Babar ZU
Ann Pharmacother; 2017 Jan; 51(1):54-65. PubMed ID: 27586430
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications in Egypt.
Farid S; Elmahdawy M; Baines D
Clin Drug Investig; 2019 Feb; 39(2):157-168. PubMed ID: 30460486
[TBL] [Abstract][Full Text] [Related]
8. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
Value Health; 2013; 16(2):e1-5. PubMed ID: 23538200
[TBL] [Abstract][Full Text] [Related]
9. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
J Med Econ; 2013; 16(6):713-9. PubMed ID: 23521434
[TBL] [Abstract][Full Text] [Related]
10. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
Alzarea AI; Khan YH; Alanazi AS; Butt MH; Almalki ZS; AlAhmari AK; Alsahali S; Mallhi TH
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805521
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of reporting quality of economic evaluations in plastic surgery based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Miroshnychenko A; Uhlman K; Malone J; Waltho D; Thoma A
J Plast Reconstr Aesthet Surg; 2021 Oct; 74(10):2458-2466. PubMed ID: 34217645
[TBL] [Abstract][Full Text] [Related]
12. Quality assessment of pharmacoeconomic abstracts of original research articles in selected journals.
Trakas K; Addis A; Kruk D; Buczek Y; Iskedjian M; Einarson TR
Ann Pharmacother; 1997 Apr; 31(4):423-8. PubMed ID: 9101002
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review and Quality Evaluation of Pharmacoeconomic Studies on Traditional Chinese Medicines.
Yang N; Zhang H; Deng T; Guo JJ; Hu M
Front Public Health; 2021; 9():706366. PubMed ID: 34414159
[No Abstract] [Full Text] [Related]
14. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S
Value Health; 2022 Jan; 25(1):10-31. PubMed ID: 35031088
[TBL] [Abstract][Full Text] [Related]
15. An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics.
Min C; Xue M; Haotian F; Jialian L; Lingli Z
PLoS One; 2021; 16(2):e0246080. PubMed ID: 33556056
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomics Evaluations of Oral Anticancer Agents: Systematic Review of Characteristics, Methodological Trends, and Reporting Quality.
Al Kadour A; Marridi WA; Al-Badriyeh D
Value Health Reg Issues; 2018 Sep; 16():46-60. PubMed ID: 30144775
[TBL] [Abstract][Full Text] [Related]
17. The state of health economic research in South Africa: a systematic review.
Gavaza P; Rascati KL; Oladapo AO; Khoza S
Pharmacoeconomics; 2012 Oct; 30(10):925-40. PubMed ID: 22809450
[TBL] [Abstract][Full Text] [Related]
18. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
BMJ; 2013 Mar; 346():f1049. PubMed ID: 23529982
[TBL] [Abstract][Full Text] [Related]
19. Assessing the quality of pharmacoeconomic studies in India: a systematic review.
Desai PR; Chandwani HS; Rascati KL
Pharmacoeconomics; 2012 Sep; 30(9):749-62. PubMed ID: 22720697
[TBL] [Abstract][Full Text] [Related]
20. Quality of pharmacoeconomic research in China: A systematic review.
Ma H; Jian W; Xu T; He Y; Rizzo JA; Fang H
Medicine (Baltimore); 2016 Oct; 95(41):e5114. PubMed ID: 27741131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
